Table 3. Communicable and Non-Communicable Disease Burden and Linkage to Care Rates Among Campaign Participants.
| HIV | Malaria | Suspected TB1 | Hypertension | Diabetes Mellitus | |||
| Prevalence | HIV+ | HIV- | |||||
| Adults (≥18 years) | 179/2,282 (7.8%) | 16/633 (2.5%) | 155/179 (87%) | 392/2,103 (19%) | 645/2,278 (28.3%) | 80/2,283 (3.5%) | |
| 15–49 years | 163/2,000 (8.1%) | 16/542 (3.0%) | 141/163 (87%) | 310/1,846 (17%) | 388/2009 (19.3%) | 32/2009 (1.6%) | |
| Children (18 mos - 17 yrs) | 10/1,826 (0.5%) | 45/534 (8.4%)2 | 10/10 (100%)2 | 455/1,816 (25%)2 | N/A | N/A | |
| Adult CHC Participants (N = 2,323) | N = 179 | N = 16 | N = 155 | N = 392 | N = 645 | N = 80 | |
| New Diagnosis | 82/179 (46%) | 16/16 (100%) | N/A | N/A | 422/645 (65%) | 18/80 (23%) | |
| Linked to care post-campaign | Routine: 20/58 (34%) Enhanced: 5/6 (83%) Overall: 25/64 (39%) 3 | N/A (Treated on-site) | 71/122 (58%) 3 | 130/252 (52%) 3 | 107/249 (43%) 4 | 11/18 (61%) 4 | |
| Prior Diagnosis | 97/179 (54%) | N/A | N/A | N/A | 223/645 (35%) | 62/80 (77%) | |
| In clinic-based care pre-campaign | 96/97 (99%) | N/A | 83/155 (54%) | N/A | N/A | N/A | |
| Receiving treatment pre-campaign | ART: 66/97 (68%)TMP/SMX: 45/97 (46%) | N/A | 2/155 (1%)5 | 15/392 (4%)5 | 85/223 (38%) | 38/62 (61%) | |
| % Not on ART of those in HIV care & CD4≤350 | 17/44 (39%) | N/A | 12/34 (35%) | N/A | N/A | N/A | |
| % Not on ART of those in HIV care & CD4≤250 | 8/24 (33%) | N/A | 4/16 (25%) | N/A | N/A | N/A | |
1
TB suspect defined in HIV-uninfected as cough >2 weeks, and in HIV-infected as current cough or fever, or any recent night sweats or weight loss.
2
Symptoms reported by parent/guardian if child <13.
3
Denominator is adults newly diagnosed with HIV or suspected TB who consented to participate in the linkage to care sub-study.
4
Denominator is adults newly diagnosed with hypertension or diabetes who scheduled appointments at the government-run hypertension/diabetes clinic.
5
Participant-reported TB treatment.
N/A = not applicable or not asked.